BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 31384813)

  • 1. Benzimidazole scaffolds as promising antiproliferative agents: a review.
    Tahlan S; Kumar S; Kakkar S; Narasimhan B
    BMC Chem; 2019 Dec; 13(1):66. PubMed ID: 31384813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The medicinal panorama of benzimidazoles and their scaffolds as anticancer and antithrombotic agents: A review.
    Chalkappa PKB; Aralihalli S; Sudileti M; Aithal SJ; Praveen BM; Birjadar K
    Arch Pharm (Weinheim); 2023 Oct; 356(10):e2300206. PubMed ID: 37440107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benzimidazole derivatives as potential anticancer agents.
    El Rashedy AA; Aboul-Enein HY
    Mini Rev Med Chem; 2013 Mar; 13(3):399-407. PubMed ID: 23190032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-silico molecular design of heterocyclic benzimidazole scaffolds as prospective anticancer agents.
    Tahlan S; Kumar S; Ramasamy K; Lim SM; Shah SAA; Mani V; Narasimhan B
    BMC Chem; 2019 Dec; 13(1):90. PubMed ID: 31384837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benzimidazole hybrids as anticancer drugs: An updated review on anticancer properties, structure-activity relationship, and mechanisms of action (2019-2021).
    Feng LS; Su WQ; Cheng JB; Xiao T; Li HZ; Chen DA; Zhang ZL
    Arch Pharm (Weinheim); 2022 Jun; 355(6):e2200051. PubMed ID: 35385159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial potential of 1
    Tahlan S; Kumar S; Narasimhan B
    BMC Chem; 2019 Dec; 13(1):18. PubMed ID: 31384767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Comprehensive Account on Recent Progress in Pharmacological Activities of Benzimidazole Derivatives.
    Brishty SR; Hossain MJ; Khandaker MU; Faruque MRI; Osman H; Rahman SMA
    Front Pharmacol; 2021; 12():762807. PubMed ID: 34803707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological significance of heterocyclic 1
    Tahlan S; Kumar S; Narasimhan B
    BMC Chem; 2019 Dec; 13(1):101. PubMed ID: 31410412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perspectives of Benzimidazole Derivatives as Anticancer Agents in the New Era.
    Yadav S; Narasimhan B; Kaur H
    Anticancer Agents Med Chem; 2016; 16(11):1403-1425. PubMed ID: 26526461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and biological profile of heterocyclic benzimidazole analogues as prospective antimicrobial and antiproliferative agents.
    Tahlan S; Kumar S; Ramasamy K; Lim SM; Shah SAA; Mani V; Pathania R; Narasimhan B
    BMC Chem; 2019 Dec; 13(1):50. PubMed ID: 31384798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent Progress of Benzimidazole Hybrids for Anticancer Potential.
    Akhtar MJ; Yar MS; Sharma VK; Khan AA; Ali Z; Haider MDR; Pathak A
    Curr Med Chem; 2020; 27(35):5970-6014. PubMed ID: 31393240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New substituted benzimidazole derivatives: a patent review (2013 - 2014).
    Wang M; Han X; Zhou Z
    Expert Opin Ther Pat; 2015 May; 25(5):595-612. PubMed ID: 25887338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functionalized Benzimidazole Scaffolds: Privileged Heterocycle for Drug Design in Therapeutic Medicine.
    Ajani OO; Aderohunmu DV; Ikpo CO; Adedapo AE; Olanrewaju IO
    Arch Pharm (Weinheim); 2016 Jul; 349(7):475-506. PubMed ID: 27213292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial Activities of 1-H-Benzimidazole-based Molecules.
    Ates-Alagoz Z
    Curr Top Med Chem; 2016; 16(26):2953-2962. PubMed ID: 27150377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and cytotoxic evaluation of novel quinozalinone derivatives with substituted benzimidazole in position 3.
    Taherian E; Khodarahmi G; Khajouei MR; Hassanzadeh F; Dana N
    Res Pharm Sci; 2019 Jun; 14(3):247-254. PubMed ID: 31160902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and Antiproliferative Activities of Benzimidazole-Based Sulfide and Sulfoxide Derivatives.
    Gaballah ST; El-Nezhawy AO; Amer H; Ali MM; Mahmoud AE; Hofinger-Horvath A
    Sci Pharm; 2016; 84(1):1-18. PubMed ID: 27110495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benzimidazole and its derivatives as cancer therapeutics: The potential role from traditional to precision medicine.
    Lee YT; Tan YJ; Oon CE
    Acta Pharm Sin B; 2023 Feb; 13(2):478-497. PubMed ID: 36873180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic, Antiproliferative and Apoptotic Effects of New Benzimidazole Derivatives on A549 Lung Carcinoma and C6 Glioma Cell Lines.
    Yurttas L; Demirayak S; Ciftci GA
    Anticancer Agents Med Chem; 2015; 15(9):1174-84. PubMed ID: 26138412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological profile of substituted benzimidazoles.
    Vashist N; Sambi SS; Narasimhan B; Kumar S; Lim SM; Shah SAA; Ramasamy K; Mani V
    Chem Cent J; 2018 Dec; 12(1):125. PubMed ID: 30506405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive Review in Current Developments of Benzimidazole-Based Medicinal Chemistry.
    Keri RS; Hiremathad A; Budagumpi S; Nagaraja BM
    Chem Biol Drug Des; 2015 Jul; 86(1):19-65. PubMed ID: 25352112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.